National Eye Institute; Notice of Closed Meetings, 63845 [2012-25439]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 201 / Wednesday, October 17, 2012 / Notices
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Gary Hunnicutt, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, 301–435–
0229, gary.hunnicutt@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Endocrinology, Metabolism,
Nutrition and Reproductive Sciences.
Date: November 14, 2012.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Dianne Camp, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, 301–435–
1044, campdm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 10, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–25440 Filed 10–16–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Eye Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI-RFA Stem Cell
Approaches to Developing New Therapies for
Ocular Diseases (R01).
VerDate Mar<15>2010
18:49 Oct 16, 2012
Jkt 229001
Date: October 23, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn, 7301 Waverly
Street, Bethesda, MD 20814.
Contact Person: Brian Hoshaw, Ph.D.,
Scientific Review Officer, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 5635 Fishers
Lane, Suite 1300, MSC 9300, 301–451–2020,
hoshawb@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Career
Development and Conference Grant
Applications—Basic Science.
Date: October 30–31, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Brian Hoshaw, Ph.D.,
Scientific Review Officer, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 5635 Fishers
Lane, Suite 1300, MSC 9300, 301–451–2020,
hoshawb@mail.nih.gov.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Clinical
Research—Anterior Eye, Myopia, Glaucoma
and Optic Nerve.
Date: November 15–16, 2012.
Time: 6:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Contact Person: Jeanette M Hosseini, Ph.D.,
Scientific Review Officer, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 5635 Fishers
Lane, Suite 1300, MSC 9300, 301–451–2020,
Jeanette.hosseini@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
63845
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: President’s Cancer
Panel;
Date: November 16, 2012.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: HPV Vaccination: Clinical
Practices, Standards, and Economic
Implications.
Place: Courtyard Chicago Downtown/
Miracle Mile, 165 East Ontario Street,
Chicago, IL 60611.
Contact Person: Abby B. Sandler, Ph.D.,
Executive Secretary, Chief, Institute Review
Office, Office of the Director, 6116 Executive
Blvd., Suite 220, MSC 8349, National Cancer
Institute, NIH, Bethesda, MD 20892–8349,
(301) 451–9399, sandlera@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/pcp/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 10, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: October 10, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–25438 Filed 10–16–12; 8:45 am]
[FR Doc. 2012–25439 Filed 10–16–12; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
President’s Cancer Panel.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 77, Number 201 (Wednesday, October 17, 2012)]
[Notices]
[Page 63845]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25439]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Eye Institute Special Emphasis
Panel; NEI-RFA Stem Cell Approaches to Developing New Therapies for
Ocular Diseases (R01).
Date: October 23, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn, 7301 Waverly Street, Bethesda, MD
20814.
Contact Person: Brian Hoshaw, Ph.D., Scientific Review Officer,
Division of Extramural Research, National Eye Institute, National
Institutes of Health, 5635 Fishers Lane, Suite 1300, MSC 9300, 301-
451-2020, hoshawb@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Eye Institute Special Emphasis
Panel; NEI Career Development and Conference Grant Applications--
Basic Science.
Date: October 30-31, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5635 Fishers Lane,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Brian Hoshaw, Ph.D., Scientific Review Officer,
Division of Extramural Research, National Eye Institute, National
Institutes of Health, 5635 Fishers Lane, Suite 1300, MSC 9300, 301-
451-2020, hoshawb@mail.nih.gov.
Name of Committee: National Eye Institute Special Emphasis
Panel; NEI Clinical Research--Anterior Eye, Myopia, Glaucoma and
Optic Nerve.
Date: November 15-16, 2012.
Time: 6:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5635 Fishers Lane,
Bethesda, MD 20892.
Contact Person: Jeanette M Hosseini, Ph.D., Scientific Review
Officer, Division of Extramural Research, National Eye Institute,
National Institutes of Health, 5635 Fishers Lane, Suite 1300, MSC
9300, 301-451-2020, Jeanette.hosseini@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.867,
Vision Research, National Institutes of Health, HHS)
Dated: October 10, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-25439 Filed 10-16-12; 8:45 am]
BILLING CODE 4140-01-P
